Inside Access, Outside the Rules - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Inside Access, Outside the Rules

Two federal cases highlight alleged misuse of professional roles in health care settings

  • By

  • Kerri Miller

  • April 1, 2026

  • 3 min

Share

Objective:

To report on recent indictments related to pharmacy and telemedicine fraud.

Key Findings:
  • Abbott is accused of illegally obtaining controlled substances like Adderall and oxycodone.
  • Harwood's scheme involved aggressive telemarketing to Medicare patients for unnecessary medical items, including orthotic braces and genetic tests.
  • Harwood faces restitution of $17.9 million and up to 20 years in prison.
Interpretation:

These cases highlight significant risks of fraud in both pharmacy and telemedicine sectors, emphasizing the need for stringent oversight.

Limitations:
  • Abbott has not been convicted and is presumed innocent until proven guilty.
  • Details on the full extent of the fraud schemes may not be fully disclosed until further legal proceedings, which could reveal additional information.
Conclusion:

The cases illustrate vulnerabilities in healthcare systems, particularly in telemedicine, where oversight can lag behind rapid service expansion.

Sources:

Original Source(s)

Inside Access, Outside the Rules

  • by Kerri Miller

  • April 1, 2026

Related Content

Oral Carbapenem Wins FDA Approval for cUTIs

Tebipenem pivoxil was noninferior to intravenous imipenem-cilastatin in hospitalized adults.

Measles-Related Vitamin A Searches Rise

Google Trends data showed increased US search interest in vitamin A and cod liver oil during the 2025 measles outbreak, but normalized search data cannot determine actual product use, dosing behavior, or harms.

FDA Approves Treg Cell Therapy

A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.